Abbott Laboratories plans to appeal a jury’s $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders. Late Monday, a jury in the Eastern District of Texas found that Abbott’…

Email this Article
Add to del.icio.us
Add to digg
Add to Facebook



Sponsored Topics:
Abbott Laboratories – United States District Court for the Eastern District of Texas – Patent infringement – Rheumatoid arthritis – Immune system

See the original post here:
Abbott plans to appeal $1.67B patent order